Skip to main content

Table 2 Antibiotic-resistant and hemolytic activity of the Bifidobacterium strains

From: In vitro evaluation of probiotic properties and antioxidant activities of Bifidobacterium strains from infant feces in the Uyghur population of northwestern China

Strain

Antibioticsa

Hemolytic activityb

TE

MH

RD

CIP

NOR

K

C

E

DA

AML

P

S

VA

AK

OX

TEC

AMP

CN

BF5-10

S

S

S

I

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF8-3

S

S

S

R

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF48-2

S

S

S

I

I

R

S

S

S

S

S

S

S

R

I

S

S

S

-

BF17-4

S

S

S

R

R

R

S

R

R

S

S

S

S

R

S

S

S

S

-

BF66-2

S

S

S

R

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF67-13

S

S

S

I

R

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF87-11

S

S

S

R

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF87-3

S

S

S

R

R

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF87-12

S

S

S

R

R

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF52-1

S

S

S

R

R

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF13-15

S

S

S

I

R

R

S

S

R

S

S

S

S

R

S

S

S

S

-

BF88-5

S

S

S

I

R

R

S

S

S

S

S

S

R

R

S

R

S

S

-

BF98-12

S

S

S

R

R

R

S

S

S

S

S

S

S

R

S

S

S

S

-

BF96-5

S

S

S

R

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

GG

S

S

S

S

I

R

S

S

S

S

S

S

S

R

S

S

S

S

-

  1. aTE tetracycline; MH minocycline; RD rifampin; CIP ciprofloxacin; NOR norfloxacin; K kanamycin; C chloramphenicol; E ergomycin; DA clindamycin; AML ampicillin; P penicillin; S streptomycin; VA vancomycin; AK amikacin; OX oxacillin; TEC cockalin; AMP ampicillin; CN gentamicin. S susceptible; I intermedio; R resistente; b -: No hemolysis